Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||-0.68%||64.74||1.0%||$426.65m|
|VRTX||Vertex Pharmaceuticals, Inc.||0.14%||294.70||1.9%||$403.06m|
|REGN||Regeneron Pharmaceuticals, Inc.||-1.17%||617.50||2.6%||$350.73m|
|SNSS||Sunesis Pharmaceuticals, Inc.||0.00%||4.15||0.7%||$290.10m|
|SAVA||Cassava Sciences, Inc.||0.11%||26.50||0.0%||$120.35m|
|GOVX||GeoVax Labs, Inc.||-6.09%||1.85||0.0%||$98.47m|
|BMRN||BioMarin Pharmaceutical, Inc.||-0.50%||92.50||4.2%||$97.46m|
|CRSP||CRISPR Therapeutics AG||-1.59%||71.00||0.6%||$89.67m|
|EXAS||EXACT Sciences Corp.||-1.48%||37.91||17.6%||$82.80m|
BioCardia, Inc. operates as a clinical-stage regenerative medicine company. It develops novel therapeutics for cardiovascular diseases. The firm offers proprietary comprehensive biotherapeutic solutions for cardiovascular disease under the CardiAMP and CardiALLO brands. It operates in only one business segment, which is a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. The company was founded on January 12, 1994 and is headquartered in Sunnyvale, CA.